A Case of Oral Cenesthopathy Treated With the Combination of Brexpiprazole and Mirtazapine

Clin Neuropharmacol. 2023 May-Jun;46(3):123-125. doi: 10.1097/WNF.0000000000000545. Epub 2023 Mar 10.

Abstract

Objectives: Oral cenesthopathy is an uncomfortable and bizarre oral sensation without corresponding organic findings. Although some treatment options, including antidepressants and antipsychotic drugs, have been reported to be effective, the condition remains refractory. Here, we report a case of oral cenesthopathy treated with brexpiprazole, a recently approved D2 partial agonist.

Methods and results: A 57-year-old woman presented with a complained of softened incisors. Furthermore, she could not perform housework because of the discomfort. The patient did not respond to aripiprazole. However, she responded to a combination of mirtazapine and brexpiprazole. The visual analog scale score for the patient's oral discomfort decreased from 90 to 61. The patient's condition improved enough to resume housework.

Conclusions: Brexpiprazole and mirtazapine may be considered for the treatment of oral cenesthopathy. Further investigations are warranted.

Publication types

  • Case Reports

MeSH terms

  • Antipsychotic Agents* / therapeutic use
  • Aripiprazole / therapeutic use
  • Female
  • Humans
  • Middle Aged
  • Mirtazapine / therapeutic use
  • Quinolones* / therapeutic use

Substances

  • brexpiprazole
  • Mirtazapine
  • Antipsychotic Agents
  • Aripiprazole
  • Quinolones